Navigation Links
AccuVein Vein Illuminator Receives European CE Mark
Date:8/4/2009

COLD SPRING HARBOR, N.Y., Aug. 4 /PRNewswire/ -- AccuVein LLC, maker of the AV300, the world's first hand-held, non-contact vein illumination device, announced today that its medical device now carries a CE Mark, enabling the Company to commence European sales of AccuVein's AV300.

"Receiving approval to ship the AV300 to Europe is an important step in bringing this beneficial device to healthcare practitioners around the globe," said Stephen P. Conlon, President of AccuVein. "Furthermore, Europe provides a significant growth opportunity for AccuVein allowing us to build upon our successful launch in the United States."

AccuVein recently achieved an International Organization for Standardization (ISO) 13485 Certification, acknowledging that its quality management processes meet international standards.

The AccuVein AV300 helps advance patient care in a variety of settings by assisting healthcare professionals in locating the vein quickly for blood draws, intravenous lines and delivery of medications. Weighing only 10 ounces, the AV300 uses point-and-click technology - the healthcare professional simply presses a button and positions the device above the patient's skin to display a map on the skin of underlying veins. With a range of hands-free options, the AV300 can quickly switch between a hand-held and hands-free mode, freeing the practitioner's hands to perform the venipuncture.

For more information on the AccuVein AV300, please visit www.AccuVein.com.

About AccuVein

AccuVein applies advanced technologies to important healthcare challenges. Their innovative AV300 allows practitioners to see a map on the patient's skin of the position of peripheral veins, helping caregivers locate these veins while they perform the most common invasive medical procedure - venipuncture. Built using AccuVein's expertise in medical device miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. With more than a dozen patents filed worldwide, AccuVein demonstrates an ongoing commitment to invest in improving patient care and patient satisfaction.

For more information on the AccuVein AV300, please visit www.AccuVein.com.

    Contacts:

    For Media Inquiries:
    Jennifer Seelin
    Makovsky + Company
    212-508-9610
    jseelin@makovsky.com

    For Sales Inquiries:
    Joe McCormick
    AccuVein LLC
    888-909-8888
    joe.mccormick@accuvein.com


'/>"/>
SOURCE AccuVein LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AccuVein Achieves Quality System Milestone
2. AccuVein AV300, First Portable Vein Illumination Device, Now Available on GSA Schedule
3. Video: AccuVein Launches First Portable, Non-Contact Vein Illumination Device
4. CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology
5. Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
6. Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
7. Hanger Orthopedic Group, Inc. Receives Upgrade From Moodys Investors Service
8. PharmaForce Inc. Receives FDA Approval for First Generic of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP
9. Caldwell College Receives Approval to Launch First Ph.D. for Applied Behavior Analysis-Autism Treatment in New Jersey
10. Pitt receives $13.4 million NIH grant to create virtual models for epidemics
11. Janet Rowley, MD, A Researcher Funded by The Leukemia & Lymphoma Society, Receives Presidential Medal of Freedom
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 29, 2017 , ... An inventor from Raynham, Mass., knows ... in conjunction with my braces always rubbed against the inside of my cheeks, ... this problem." The O.B.S. was the result of his brainstorming. , This patent-pending ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an ... 20, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , Home health and hospice companies are still popular targets for healthcare investors. ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... in many scientific laboratories. The assembly protocols involve many repetitive steps and often ... for automation, which enables the high-throughput needed, and results in a lower error ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
(Date:3/29/2017)... CA (PRWEB) , ... March 29, 2017 , ... Hamlin ... Northridge , is now offering laser dental treatments. Dental lasers are safe and effective ... dentistry expands patients’ options and can improve the overall quality of care. , Dr. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Neurim Pharmaceuticals ("Neurim") and Exeltis announced today ... for Neurim,s new Rx PedPRM in Spain . ... Neurim,s paediatric prolonged-release ... children with Autism Spectrum Disorders (ASD) and neurogenetic diseases. It is ... The collaboration with Exeltis will help increase the accessibility of ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... Software Market Outlook: 2016-2022" report to their offering. ... The global patient safety ... of delivery, end-user, and geography. Patient safety has ... globe. The field has developed significantly in the last decade and ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
Breaking Medicine Technology: